Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
- PMID: 10646909
- PMCID: PMC2363299
- DOI: 10.1054/bjoc.1999.0947
Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
Abstract
The role of DNA topoisomerases (Topo) IIalpha and IIbeta was investigated in various drug-resistant melanoma cells. Melanoma cells resistant to etoposide, exhibited an up to tenfold reduced Topo II activity corresponding to an increasing degree of drug resistance indicating that modulation of Topo II activity contribute to the drug-resistant phenotype. The reduction of Topo II activity was reflected by decreased nuclear amounts of both Topo II isoforms.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical